Geneva, Jan. 12 -- International Clinical Trials Registry received information related to the study (ChiCTR2600116012) titled 'Research on Machine Learning-Based Prediction of Immune Checkpoint Inhibitor Treatment Response Using Tongue Image Data' on Jan. 4.
Study Type: Observational study
Study Design:
Sequential
Primary Sponsor: Guangdong Provincial Hospital of Traditional Chinese Medicine
Condition:
Patients with pathologically confirmed solid malignant tumors (e.g., lung cancer, liver cancer, gastric cancer, etc.)
Recruitment Status: Not Recruiting
Phase: N/A
Date of First Enrollment: 2026-01-04
Target Sample Size: Observation Group of Solid Malignant Tumors:360;
Countries of Recruitment:
China
To know more, visit http...